SCHEMBL7190672

SCHEMBL7190672

CC1(C)CC(C)(C)c2cccc(SN)c2O1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.33
CYP26B1 Q9NR63 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7150221 0.76 CYP26A1 (0.45) CYP26A1CYP26B1
SCHEMBL8729047 0.75 CYP26A1 (0.35) CYP26A1CYP26B1
SCHEMBL8561686 0.66 AKR1B1 (0.35) CYP26A1CYP26B1
SCHEMBL7195927 0.65 AKR1B1 (0.35) CYP26A1CYP26B1
SCHEMBL6032601 0.61 HNF4A (0.30)
SCHEMBL21750684 0.60
SCHEMBL21750642 0.60
SCHEMBL2353102 0.58 HTR2A (0.39)
SCHEMBL30695310 0.58 HTR2A (0.39)
SCHEMBL9054386 0.58 MAPT (0.42) CYP26A1CYP26B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586460-B1 Administering heterocyclic ethers or sulfides to induce apoptosis, cell differentiation and as anticarcinogenic agents THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY 2003-07-01 US disclosed